A phase 1 study of concurrent late course accelerated hyper-fractionated radiotherapy and capecitabine and cisplatin for local advanced esophageal cancer

被引：2
作者：
Li, B. [1 ]
Yan, J. [1 ]
Zhou, T. [1 ]
Wang, Z. [1 ]
Li, H. [1 ]
Sun, H. [1 ]
机构：
[1] Shandong Tumor Hosp, Jinan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2008.06.1744
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S283 / S283
页数：1
相关论文
共 50 条
  • [31] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin for locally advanced head and neck cancer: A preliminary result.
    Kim, JG
    Baek, JH
    Sohn, SK
    Kim, DH
    Jeon, SB
    Park, JS
    Sohn, JH
    Kim, JC
    Park, IK
    Park, KU
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 521S - 521S
  • [32] Phase II neoadjuvant docetaxel/cisplatin followed by concurrent cisplatin/radiotherapy for locally advanced nasopharyngeal cancer
    Kandil, M. S.
    Alnasser, H. S.
    Bandey, S. A.
    Almutairy, A. S.
    Ammar, F. A.
    Saadeddin, A. A.
    Murshid, E. M.
    Asiri, M. A.
    Zahrani, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Phase II trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer
    De Las Heras, M.
    Arias, F.
    Del Moral, R.
    Gomez-Millán, J.
    Jiménez, E.
    Wals, A.
    Alcántara, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S305 - S305
  • [34] Concurrent chemoradiotherapy with S-1 and cisplatin for locally advanced esophageal cancer
    Iwase, H.
    Shimada, M.
    Tsuzuki, T.
    Okeya, M.
    Kobayashi, K.
    Watanabe, H.
    Hibino, Y.
    Ryuge, N.
    Goto, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] A phase II trial of induction chemotherapy with cisplatin, docetaxel, and capecitabine followed by concurrent cisplatin-radiotherapy in advanced nasopharyngeal carcinoma.
    Yamouni, M.
    Beldjilali, Y.
    Benhadji, K. A.
    Khellafi, H.
    Betkaoui, F.
    Kaid, Y.
    Benchlef, L.
    Daim, F. Z.
    Toubal, S.
    Boukerche, A.
    Abdelaoui, A.
    Djellali, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] Irinotecan and cisplatin with concurrent split-course radiotherapy in locally advanced nonsmall-cell lung cancer - A multiinstitutional phase 2 study
    Fukuda, Minoru
    Soda, Hiroshi
    Fukuda, Masaaki
    Kinoshita, Akitoshi
    Nakamura, Yoichi
    Nagashima, Seiji
    Takatani, Hiroshi
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    Oka, Mikio
    CANCER, 2007, 110 (03) : 606 - 613
  • [37] Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer
    Ilson, DH
    Bains, M
    Kelsen, DP
    O'Reilly, E
    Karpeh, M
    Coit, D
    Rusch, V
    Gonen, M
    Wilson, K
    Minsky, BD
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) : 2926 - 2932
  • [38] Neoadjuvant chemotherapy followed by either continuous hyper-fractionated accelerated radiation therapy week-end less or conventional chemo-radiotherapy in locally advanced non small cell lung cancer
    Sinwer, R. K.
    Kumar, H. S.
    Paramanandhan, M.
    Purohit, R.
    Sharma, N.
    Sharma, S. N.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S108 - S108
  • [39] Concurrent radiotherapy with capecitabine and weekly irinotecan as neoadjuvant treatment for locally advanced rectal cancer: a phase I/II study
    Klautke, Gunther
    Feyerherd, Peter
    Ludwig, Kaja
    Foitzik, Thomas
    Klar, Ernst
    Fietkau, Rainer
    ANNALS OF ONCOLOGY, 2004, 15 : 80 - 80
  • [40] Phase one dose finding study of capecitabine (Xeloda®), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer
    Stokes, Z
    Symonds, P
    Habeshaw, T
    Reed, N
    Curto, J
    Joynson, C
    Chan, S
    GYNECOLOGIC ONCOLOGY, 2005, 97 (03) : 790 - 795
12345